UK Markets close in 12 mins

Novo Nordisk A/S (NOVO-B.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
805.00-3.30 (-0.41%)
At close: 04:59PM CEST
Currency in DKK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.32
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3834.50
52-week low 3534.70
50-day moving average 3770.68
200-day moving average 3717.19

Share statistics

Avg vol (3-month) 31.89M
Avg vol (10-day) 31.48M
Shares outstanding 51.74B
Implied shares outstanding 6N/A
Float 81.62B
% held by insiders 17.02%
% held by institutions 141.08%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 410.4
Forward annual dividend yield 41.39%
Trailing annual dividend rate 39.35
Trailing annual dividend yield 31.16%
5-year average dividend yield 42.16
Payout ratio 448.35%
Dividend date 3N/A
Ex-dividend date 425 Mar 2022
Last split factor 25:1
Last split date 302 Jan 2014

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Mar 2022

Profitability

Profit margin 33.11%
Operating margin (ttm)42.61%

Management effectiveness

Return on assets (ttm)23.45%
Return on equity (ttm)78.92%

Income statement

Revenue (ttm)149.03B
Revenue per share (ttm)65.13
Quarterly revenue growth (yoy)24.30%
Gross profit (ttm)117.14B
EBITDA 67.99B
Net income avi to common (ttm)49.34B
Diluted EPS (ttm)19.98
Quarterly earnings growth (yoy)12.60%

Balance sheet

Total cash (mrq)20.15B
Total cash per share (mrq)8.85
Total debt (mrq)25.48B
Total debt/equity (mrq)38.29
Current ratio (mrq)0.90
Book value per share (mrq)28.85

Cash flow statement

Operating cash flow (ttm)67.33B
Levered free cash flow (ttm)54.22B